Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
AGC Biologics Expands Cell Therapy Development Operations to Asia to Serve Growing Market Need
Thursday, June 26, 2025Today we announced we will commence cell therapy process development and clinical manufacturing services on July at AGC Incs Yokohama Technical Center marking the latest step in the global expansion of the companys
Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus
Thursday, June 26, 2025Valneva SE a specialty vaccine company today announced an exclusive agreement with CSL Seqirus one of the worlds largest influenza vaccine companies for the marketing and distribution of Valnevas three proprietary vaccines in Germany
Novartis completes acquisition of Regulus Therapeutics
Thursday, June 26, 2025Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc Regulus With the completion of the acquisition shares of common stock par value per share the Shares
Teva becomes secondary commercialization partner for Formycon's Stelara® biosimilar FYB202 (ustekinumab) under the brand name Fymskina® in Germany
Thursday, June 26, 2025Formycon AGannounces that it has entered into a distribution agreement with ratiopharm GmbH Ratiopharm a subsidiary of the Teva Group Teva for the semiexclusive commercialization of its Stelara biosimilar FYBFymskina in Germany
LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success
Thursday, June 26, 2025LTS LOHMANN TherapieSysteme AG LTS a leading pharmaceutical technology company and Nualtis formerly IntelGenx Corp an innovator in oral thin film OTF drug delivery technology
BioCity's ETA-Selective Antagonist SC0062 Granted Breakthrough Therapy Designation in China for Diabetic Kidney Disease with Albuminuria
Thursday, June 26, 2025BioCity Biopharma BioCity announced today that the Center for Drug Evaluation CDE of Chinas National Medical Products Administration NMPA has granted Breakthrough Therapy Designation BTD
Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization
Wednesday, June 25, 2025Regeneron Pharmaceuticals Inctoday announced the launch of a pioneering matching program for donations to Good Days an independent national nonprofit charitable organization to support Good Days
Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin
Wednesday, June 25, 2025Fortrea a leading global contract research organization CRO today announced a strategic collaboration with Emery Pharma a leading analytical and bioanalytical CRO providing testing services under current Good Manufacturing Practice
Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea
Wednesday, June 25, 2025Ono Pharmaceutical Co Ltd and Vertex Pharmaceuticals Incorporated today announced an exclusive collaboration and license agreement for the development and commercialization of Vertexs povetacicept in Japan and South Korea
Pharma and CHICO Pharmaceutical Sign a Strategic MoU for Oncology API Tech Transfer Bridging China and the Middle East to Strengthen Regional Supply chains and Impact Millions of Cancer
Wednesday, June 25, 2025EVA Pharma one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle East and Africa and CHICO Pharmaceutical a hightech enterprise specializing in CDMO services for pharmaceutical
